Literature DB >> 17991624

Rectum dose reduction and individual treatment plan optimization for high-dose-rate prostate brachytherapy.

Tobias Bölling1, Christos Moustakis, Hassan Elsayed, Stefan-Bodo Müller, Christoph Weining, Gabriele Reinartz, Iris Ernst, Normann Willich, Stefan Könemann.   

Abstract

PURPOSE: Different doses and techniques used in high-dose-rate (HDR) prostate brachytherapy make it difficult to define universal quality parameters. The aim of this study was to develop individual, objective parameters for the evaluation of an HDR brachytherapy plan for prostate radiation.
METHODS: Fifty-three patients who received an HDR brachytherapy boost after external radiation were analyzed in this study. Brachytherapy was performed with a (192)Ir source after ultrasound-guided, transperineal metal needle application followed by removal of the ultrasound probe to reduce organ dose levels at the anterior rectum wall. The rectum and prostate locations as well as the dose at the anterior rectum wall were estimated under the anatomical conditions of HDR prostate brachytherapy. The doses at the organs at risk (rectum and urethra) were analyzed for several parameters, which were compared to values of former patients before the start of treatment. In cases of major deviations, modifications of the treatment plan were performed before starting the treatment.
RESULTS: Deflating of the water balloon led to an increase of the space between the anterior rectal wall and the dorsal margin of the prostate (mean, 6mm; 1-10mm). The dose of the introduced "virtual rectum," represented by the ventral surface of the ultrasound probe, in the treatment plan correlated to dose measurements in the rectum. Pretreatment evaluation and comparison of the established individual quality parameters led in two cases to a treatment plan modification.
CONCLUSIONS: This method allows a fast and objective individual brachytherapy treatment plan evaluation and improvement.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991624     DOI: 10.1016/j.brachy.2007.06.001

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  2 in total

1.  Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer.

Authors:  Georgina Fröhlich; Péter Agoston; József Lövey; András Somogyi; János Fodor; Csaba Polgár; Tibor Major
Journal:  Strahlenther Onkol       Date:  2010-06-24       Impact factor: 3.621

2.  An evaluation of the robustness of organ-at-risk recommendations made by GEC/ESTRO according to interobserver variability: a single-center experience.

Authors:  Rodolfo Chicas-Sett; Francisco Celada-Alvarez; Susana Roldán; Asunción Torregrosa; Jesus Betancourt; Juan Bautista-Ballesteros; Dolores Farga; Blanca Ibañez; Alejandro Tormo; Jose Perez-Calatayud
Journal:  J Contemp Brachytherapy       Date:  2016-08-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.